Group 1 - The United States and China are engaged in a dispute over the sale of precursor chemicals for fentanyl, with the U.S. accusing China of inadequate enforcement while China labels the U.S. claims as false [1][1][1] - The U.S. has highlighted that millions of tons of chemical precursors for fentanyl are produced in China, attributing the issue to China's weak export controls and lax enforcement [1][1][1] - An agreement between the U.S. and China, established last year, involved the U.S. reducing tariffs on China in exchange for China's commitment to combat the illicit fentanyl trade [1][1][1] Group 2 - The U.S. Supreme Court recently invalidated a 10% fentanyl-related tariff imposed by the Trump administration, but the U.S. plans to reimpose this tariff under a different legal framework [1][1][1] - China's envoy criticized the U.S. for using drug issues as a pretext for unilateral actions and emphasized the need for international cooperation rather than sanctions [1][1][1] - The ongoing tensions between the U.S. and China over drug control and tariffs are expected to be a topic of discussion during an upcoming meeting between the leaders of both countries [1][1][1]

US-India Relations & Fentanyl Trade - US-India relations soured earlier this year [1] - Drug-control experts briefed the Trump administration on India's role in the trade of chemicals used to make fentanyl [1] Fentanyl Production - The report highlights India's involvement in the murky trade of chemicals used to produce fentanyl [1]